What are the causes of elevated D-dimer (D-dimer) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated D-dimer Levels

Elevated D-dimer levels are primarily caused by venous thromboembolism (VTE), sepsis, and cancer, which collectively account for approximately 89% of cases with extremely elevated levels (>5000 μg/L). 1

Common Causes of Elevated D-dimer

D-dimer is a biomarker that represents both coagulation (fibrin clot formation) and fibrinolysis (fibrin clot degradation). It is generated when crosslinked fibrin is digested by plasmin 2. The following conditions commonly cause D-dimer elevation:

Thrombotic Conditions

  • Pulmonary embolism (PE) - present in 32% of patients with extremely elevated D-dimer 1
  • Deep vein thrombosis (DVT) - present in 13% of patients with extremely elevated D-dimer 1
  • Cerebral venous thrombosis (CVT) 3
  • Disseminated intravascular coagulation (DIC) 2

Inflammatory and Infectious Conditions

  • Sepsis - present in 24% of patients with extremely elevated D-dimer 1
  • COVID-19 - associated with disease severity and mortality 2
  • Acute respiratory distress syndrome (ARDS) 2
  • Other inflammatory conditions 3

Malignancy

  • Active cancer - present in 29% of patients with extremely elevated D-dimer 1
  • New or previously diagnosed active cancer 4

Trauma and Surgical Conditions

  • Recent surgery or trauma - present in 24% of patients with extremely elevated D-dimer 1
  • Post-operative states 3

Cardiovascular Conditions

  • Myocardial infarction 2
  • Aortic dissection - can present with markedly elevated D-dimer 4

Physiological States

  • Advanced age - requires age-adjusted cutoffs (age × 10 μg/L) for patients over 50 years 3
  • Pregnancy - normal ranges vary by trimester:
    • First trimester: 0.11-0.40 μg/mL
    • Second trimester: 0.14-0.75 μg/mL
    • Third trimester: 0.16-1.3 μg/mL 3

Clinical Significance of D-dimer Elevation

Diagnostic Value

  • Normal D-dimer (<500 μg/L) has high negative predictive value for VTE in low and intermediate pretest probability patients 3
  • D-dimer has a long half-life (~16 hours), which makes single time-point measurements difficult to interpret 2
  • Sequential measurements may be needed to confirm active fibrinolysis 2

Prognostic Significance

  • Extremely elevated D-dimer (>5000 μg/L) is highly specific for serious illness 1
  • Elevated D-dimer is independently associated with increased risk for:
    • Incident VTE
    • Recurrent VTE
    • Mortality 5

Special Considerations

  • D-dimer testing methods vary significantly between laboratories 3
  • Standard cutoff is 500 μg/L FEU (Fibrinogen Equivalent Units) 3
  • Age-adjusted cutoff (age × 10 μg/L) improves specificity while maintaining sensitivity in patients over 50 years 3
  • Critically elevated D-dimer levels (≥5 mg/mL) require therapeutic anticoagulation and thorough investigation for underlying thrombosis 3

Clinical Pitfalls and Caveats

  • D-dimer assays are neither standardized nor harmonized, making comparison between studies and laboratories difficult 2
  • Up to 10-fold differences have been observed between different ELISA kits measuring the same samples 2
  • A second rise in D-dimer values after initial normalization may indicate development of pathologic thrombosis, particularly in trauma patients 6
  • In patients with markedly elevated D-dimer and negative CTPA for PE, consider other serious conditions including:
    • Occult malignancy
    • Aortic dissection
    • Severe infection 4
  • For patients with high pretest probability of VTE, proceed directly to appropriate imaging regardless of D-dimer result 3

D-dimer elevation should never be dismissed as non-specific, especially when levels are markedly elevated, as these almost always indicate serious underlying pathology requiring prompt evaluation and management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Thrombotic Events

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

D-Dimer elevation and adverse outcomes.

Journal of thrombosis and thrombolysis, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.